| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 3.54e-05 | 14 | 94 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 4.94e-05 | 43 | 94 | 4 | GO:0008307 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | FCER2 OBSCN ANGPTL3 FGF2 RDX DMD DHX29 ADAM22 SVEP1 CNTN1 MSN | 1.17e-04 | 599 | 94 | 11 | GO:0050839 |
| GeneOntologyMolecularFunction | GPI anchor binding | 1.67e-04 | 23 | 94 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | integrin binding | 1.79e-04 | 175 | 94 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 2.43e-04 | 26 | 94 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 3.33e-04 | 70 | 94 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | filamin binding | 3.38e-04 | 29 | 94 | 3 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 3.38e-04 | 29 | 94 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 3.91e-04 | 73 | 94 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 5.44e-04 | 34 | 94 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 1.36e-03 | 173 | 94 | 5 | GO:0070851 | |
| GeneOntologyMolecularFunction | glycolipid binding | 1.59e-03 | 49 | 94 | 3 | GO:0051861 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.51e-07 | 28 | 93 | 5 | GO:0034111 | |
| GeneOntologyBiologicalProcess | endothelial cell differentiation | 5.82e-07 | 158 | 93 | 8 | GO:0045446 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 8.81e-07 | 17 | 93 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | endothelium development | 1.69e-06 | 182 | 93 | 8 | GO:0003158 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 3.21e-06 | 23 | 93 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 4.04e-06 | 53 | 93 | 5 | GO:0034110 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.11e-05 | 31 | 93 | 4 | GO:0010544 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 1.20e-05 | 66 | 93 | 5 | GO:0010543 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 1.29e-05 | 67 | 93 | 5 | GO:0045601 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 1.82e-05 | 35 | 93 | 4 | GO:1901142 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 2.08e-05 | 124 | 93 | 6 | GO:0034109 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 3.12e-05 | 14 | 93 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 3.80e-05 | 42 | 93 | 4 | GO:0090330 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 3.88e-05 | 15 | 93 | 3 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 3.88e-05 | 15 | 93 | 3 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 3.88e-05 | 15 | 93 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.88e-05 | 15 | 93 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 4.76e-05 | 16 | 93 | 3 | GO:0038016 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | FCER2 PSG2 PSG11 APC2 ASPH FGF2 ROCK1 PARN ROS1 PSG8 MAP3K13 FGFR4 PPP2R3C CTSD IL23R | 5.33e-05 | 1028 | 93 | 15 | GO:0043085 |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 5.76e-05 | 17 | 93 | 3 | GO:0070342 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 5.76e-05 | 17 | 93 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | FCER2 PSG2 PSG11 WNT2 BTK APC2 ASPH FGF2 ROCK1 PARN ROS1 PSG8 MAP3K13 FGFR4 DMD PPP2R3C CTSD IL23R | 6.09e-05 | 1430 | 93 | 18 | GO:0044093 |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 6.89e-05 | 18 | 93 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 7.03e-05 | 95 | 93 | 5 | GO:0070527 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | 7.24e-05 | 490 | 93 | 10 | GO:0051347 | |
| GeneOntologyBiologicalProcess | platelet activation | 8.08e-05 | 158 | 93 | 6 | GO:0030168 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 8.16e-05 | 98 | 93 | 5 | GO:0061045 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 8.67e-05 | 232 | 93 | 7 | GO:0002706 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 8.92e-05 | 405 | 93 | 9 | GO:0033674 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | SDK2 CD244 PSG2 PSG11 ENTPD1 ADAMTS18 SMARCC1 RDX ROCK1 PSG8 SVEP1 IL23R CNTN1 IGDCC4 MSN | 9.01e-05 | 1077 | 93 | 15 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 9.57e-05 | 20 | 93 | 3 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.11e-04 | 21 | 93 | 3 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.11e-04 | 21 | 93 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.11e-04 | 21 | 93 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 1.25e-04 | 246 | 93 | 7 | GO:0045216 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 1.28e-04 | 22 | 93 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.47e-04 | 23 | 93 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 1.68e-04 | 24 | 93 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 1.68e-04 | 24 | 93 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 1.68e-04 | 24 | 93 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 1.90e-04 | 25 | 93 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 1.90e-04 | 25 | 93 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | organ induction | 2.14e-04 | 26 | 93 | 3 | GO:0001759 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 2.40e-04 | 27 | 93 | 3 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 2.66e-04 | 126 | 93 | 5 | GO:1903035 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 2.68e-04 | 69 | 93 | 4 | GO:0030195 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 2.83e-04 | 70 | 93 | 4 | GO:1900047 | |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 2.96e-04 | 129 | 93 | 5 | GO:0043406 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 2.98e-04 | 29 | 93 | 3 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 3.15e-04 | 72 | 93 | 4 | GO:0050819 | |
| GeneOntologyBiologicalProcess | phosphate ion transport | 3.64e-04 | 31 | 93 | 3 | GO:0006817 | |
| GeneOntologyBiologicalProcess | regulation of animal organ formation | 4.00e-04 | 32 | 93 | 3 | GO:0003156 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 4.00e-04 | 32 | 93 | 3 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 4.00e-04 | 32 | 93 | 3 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 4.00e-04 | 32 | 93 | 3 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 4.39e-04 | 33 | 93 | 3 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 4.39e-04 | 33 | 93 | 3 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation | 4.51e-04 | 217 | 93 | 6 | GO:0030856 | |
| GeneOntologyBiologicalProcess | endothelial cell development | 4.71e-04 | 80 | 93 | 4 | GO:0001885 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 4.80e-04 | 34 | 93 | 3 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 4.80e-04 | 34 | 93 | 3 | GO:0046851 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 4.99e-04 | 309 | 93 | 7 | GO:0002703 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 5.39e-04 | 147 | 93 | 5 | GO:0031341 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 5.42e-04 | 83 | 93 | 4 | GO:0002707 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | CD244 PSG2 PSG11 FGF2 ROCK1 ROS1 PSG8 MAP3K13 FGFR4 PPP2R3C IL23R CNTN1 | 5.80e-04 | 879 | 93 | 12 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | CD244 PSG2 PSG11 FGF2 ROCK1 ROS1 PSG8 MAP3K13 FGFR4 PPP2R3C IL23R CNTN1 | 5.80e-04 | 879 | 93 | 12 | GO:0010562 |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 5.93e-04 | 85 | 93 | 4 | GO:1903670 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 6.68e-04 | 38 | 93 | 3 | GO:2000345 | |
| GeneOntologyBiologicalProcess | positive regulation of early endosome to late endosome transport | 7.09e-04 | 9 | 93 | 2 | GO:2000643 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 7.21e-04 | 39 | 93 | 3 | GO:0045717 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 7.67e-04 | 91 | 93 | 4 | GO:0030193 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 7.77e-04 | 40 | 93 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 8.32e-04 | 93 | 93 | 4 | GO:1900046 | |
| GeneOntologyBiologicalProcess | positive regulation of animal organ morphogenesis | 8.36e-04 | 41 | 93 | 3 | GO:0110110 | |
| GeneOntologyBiologicalProcess | developmental induction | 8.36e-04 | 41 | 93 | 3 | GO:0031128 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 8.36e-04 | 41 | 93 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | specification of animal organ identity | 8.36e-04 | 41 | 93 | 3 | GO:0010092 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to early endosome | 8.84e-04 | 10 | 93 | 2 | GO:1902965 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to early endosome | 8.84e-04 | 10 | 93 | 2 | GO:1902966 | |
| GeneOntologyBiologicalProcess | regulation of phosphate transport | 8.84e-04 | 10 | 93 | 2 | GO:0010966 | |
| GeneOntologyBiologicalProcess | regulation of wound healing | 9.34e-04 | 166 | 93 | 5 | GO:0061041 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 9.37e-04 | 96 | 93 | 4 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 9.37e-04 | 96 | 93 | 4 | GO:0050818 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 1.04e-03 | 350 | 93 | 7 | GO:0045860 | |
| GeneOntologyBiologicalProcess | regulation of transferase activity | PSG2 PSG11 FGF2 PARN ROS1 PSG8 MAP3K13 FGFR4 PPP2R3C TERF1 IL23R | 1.04e-03 | 810 | 93 | 11 | GO:0051338 |
| GeneOntologyBiologicalProcess | cell activation | SCN11A FCRL1 CD244 FCER2 PSG2 PSG11 BTK ENTPD1 ADAMTS18 SMARCC1 PSG8 PPP2R3C SVEP1 IL23R MSN | 1.05e-03 | 1356 | 93 | 15 | GO:0001775 |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 1.10e-03 | 45 | 93 | 3 | GO:0048521 | |
| GeneOntologyBiologicalProcess | blood coagulation | 1.16e-03 | 260 | 93 | 6 | GO:0007596 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 1.17e-03 | 46 | 93 | 3 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 1.17e-03 | 46 | 93 | 3 | GO:0072574 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | FOXJ2 PSG2 BTBD7 PSG11 WNT2 ANGPTL3 FGF2 RDX ROCK1 PSG8 MAP3K13 FGFR4 MSN | 1.19e-03 | 1090 | 93 | 13 | GO:0022603 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 1.25e-03 | 47 | 93 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 1.25e-03 | 47 | 93 | 3 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 1.25e-03 | 47 | 93 | 3 | GO:0034104 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 1.27e-03 | 178 | 93 | 5 | GO:0022612 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell proliferation | 1.29e-03 | 12 | 93 | 2 | GO:0032819 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 1.30e-03 | 266 | 93 | 6 | GO:0033044 | |
| GeneOntologyBiologicalProcess | coagulation | 1.30e-03 | 266 | 93 | 6 | GO:0050817 | |
| GeneOntologyBiologicalProcess | hemostasis | 1.35e-03 | 268 | 93 | 6 | GO:0007599 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.41e-03 | 49 | 93 | 3 | GO:0072576 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 4.58e-05 | 16 | 93 | 3 | GO:0070021 | |
| MousePheno | increased abdominal fat pad weight | 1.66e-05 | 27 | 81 | 4 | MP:0009286 | |
| MousePheno | decreased susceptibility to Riboviria infection | 1.11e-04 | 82 | 81 | 5 | MP:0020914 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 1.19e-04 | 44 | 81 | 4 | MP:0031023 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 1.20e-04 | 17 | 81 | 3 | MP:0031047 | |
| Domain | IGc2 | 2.40e-07 | 235 | 92 | 10 | SM00408 | |
| Domain | Ig_sub2 | 2.40e-07 | 235 | 92 | 10 | IPR003598 | |
| Domain | Chromo/shadow_dom | 5.53e-07 | 33 | 92 | 5 | IPR000953 | |
| Domain | CHROMO | 5.53e-07 | 33 | 92 | 5 | SM00298 | |
| Domain | Ig_2 | 1.58e-06 | 73 | 92 | 6 | PF13895 | |
| Domain | - | FAM187B SDK2 FCRL1 CD244 PSG2 PSG7 PSG11 OBSCN ROS1 PSG8 FGFR4 IL23R CNTN1 IGDCC4 | 4.29e-06 | 663 | 92 | 14 | 2.60.40.10 |
| Domain | Ig-like_dom | FAM187B SDK2 FCRL1 CD244 PSG2 PSG7 PSG11 OBSCN PSG8 FGFR4 CNTN1 IGDCC4 | 6.56e-06 | 503 | 92 | 12 | IPR007110 |
| Domain | IG | SDK2 FCRL1 CD244 PSG2 PSG7 PSG11 OBSCN PSG8 FGFR4 CNTN1 IGDCC4 | 6.99e-06 | 421 | 92 | 11 | SM00409 |
| Domain | Ig_sub | SDK2 FCRL1 CD244 PSG2 PSG7 PSG11 OBSCN PSG8 FGFR4 CNTN1 IGDCC4 | 6.99e-06 | 421 | 92 | 11 | IPR003599 |
| Domain | Chromo | 7.59e-06 | 26 | 92 | 4 | PF00385 | |
| Domain | Ig-like_fold | FAM187B SDK2 FCRL1 CD244 PSG2 PSG7 PSG11 OBSCN ROS1 PSG8 FGFR4 IL23R CNTN1 IGDCC4 | 8.79e-06 | 706 | 92 | 14 | IPR013783 |
| Domain | CHROMO_1 | 1.03e-05 | 28 | 92 | 4 | PS00598 | |
| Domain | CHROMO_2 | 1.03e-05 | 28 | 92 | 4 | PS50013 | |
| Domain | Chromodomain-like | 1.78e-05 | 32 | 92 | 4 | IPR016197 | |
| Domain | IG_LIKE | SDK2 FCRL1 CD244 PSG2 PSG7 PSG11 OBSCN PSG8 FGFR4 CNTN1 IGDCC4 | 2.92e-05 | 491 | 92 | 11 | PS50835 |
| Domain | Ig_I-set | 4.26e-05 | 190 | 92 | 7 | IPR013098 | |
| Domain | ig | 4.26e-05 | 190 | 92 | 7 | PF00047 | |
| Domain | Immunoglobulin | 4.26e-05 | 190 | 92 | 7 | IPR013151 | |
| Domain | I-set | 4.26e-05 | 190 | 92 | 7 | PF07679 | |
| Domain | ERM_C_dom | 1.43e-04 | 4 | 92 | 2 | IPR011259 | |
| Domain | ERM | 1.43e-04 | 4 | 92 | 2 | PF00769 | |
| Domain | ERM | 1.43e-04 | 4 | 92 | 2 | IPR011174 | |
| Domain | fn3 | 1.50e-04 | 162 | 92 | 6 | PF00041 | |
| Domain | FN3 | 3.07e-04 | 185 | 92 | 6 | SM00060 | |
| Domain | FN3 | 4.52e-04 | 199 | 92 | 6 | PS50853 | |
| Domain | Moesin_tail | 4.96e-04 | 7 | 92 | 2 | IPR008954 | |
| Domain | FN3_dom | 5.86e-04 | 209 | 92 | 6 | IPR003961 | |
| Domain | Na_channel_asu | 1.05e-03 | 10 | 92 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 1.05e-03 | 10 | 92 | 2 | IPR010526 | |
| Domain | Chromo_dom_subgr | 1.05e-03 | 10 | 92 | 2 | IPR017984 | |
| Domain | Na_trans_assoc | 1.05e-03 | 10 | 92 | 2 | PF06512 | |
| Domain | PROTEIN_KINASE_TYR | 1.35e-03 | 97 | 92 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.35e-03 | 97 | 92 | 4 | IPR008266 | |
| Domain | Kinase-like_dom | 1.40e-03 | 542 | 92 | 9 | IPR011009 | |
| Domain | Ig_V-set | 3.04e-03 | 199 | 92 | 5 | IPR013106 | |
| Domain | Crotonase_core_superfam | 3.11e-03 | 17 | 92 | 2 | IPR001753 | |
| Domain | ECH_1 | 3.11e-03 | 17 | 92 | 2 | PF00378 | |
| Domain | - | 3.18e-03 | 391 | 92 | 7 | 2.30.29.30 | |
| Domain | Chromodomain_CS | 3.49e-03 | 18 | 92 | 2 | IPR023779 | |
| Domain | Pkinase_Tyr | 3.80e-03 | 129 | 92 | 4 | PF07714 | |
| Domain | Ez/rad/moesin-like | 4.74e-03 | 21 | 92 | 2 | IPR000798 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 4.83e-03 | 138 | 92 | 4 | IPR001245 | |
| Domain | PH_dom-like | 5.08e-03 | 426 | 92 | 7 | IPR011993 | |
| Domain | Chromo_domain | 6.17e-03 | 24 | 92 | 2 | IPR023780 | |
| Domain | FERM_CS | 6.17e-03 | 24 | 92 | 2 | IPR019747 | |
| Domain | FERM_C | 7.22e-03 | 26 | 92 | 2 | PF09380 | |
| Domain | MetalloPept_cat_dom | 7.48e-03 | 81 | 92 | 3 | IPR024079 | |
| Domain | - | 7.48e-03 | 81 | 92 | 3 | 3.40.390.10 | |
| Domain | FERM_C | 7.78e-03 | 27 | 92 | 2 | SM01196 | |
| Domain | FERM_PH-like_C | 7.78e-03 | 27 | 92 | 2 | IPR018980 | |
| Domain | TyrKc | 9.39e-03 | 88 | 92 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 9.39e-03 | 88 | 92 | 3 | IPR020635 | |
| Pathway | PID_RHOA_PATHWAY | 7.12e-05 | 45 | 70 | 4 | M12 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 9.83e-05 | 150 | 70 | 6 | M39520 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 1.06e-04 | 152 | 70 | 6 | MM15834 | |
| Pubmed | 8.14e-08 | 4 | 96 | 3 | 18941185 | ||
| Pubmed | 3.52e-07 | 162 | 96 | 7 | 25826454 | ||
| Pubmed | 4.05e-07 | 6 | 96 | 3 | 16029194 | ||
| Pubmed | Mammalian chromodomain proteins: their role in genome organisation and expression. | 1.13e-06 | 8 | 96 | 3 | 10655032 | |
| Pubmed | 1.13e-06 | 8 | 96 | 3 | 1690992 | ||
| Pubmed | ARL1 ARHGAP23 ASPH SMARCC1 MPDZ RDX PARN TASOR SEC23B MAN1B1 MSN | 1.87e-06 | 650 | 96 | 11 | 38777146 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 5.71e-06 | 13 | 96 | 3 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 5.71e-06 | 13 | 96 | 3 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 5.71e-06 | 13 | 96 | 3 | 16638824 | |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 20044046 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 32150576 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 6265583 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 5.71e-06 | 13 | 96 | 3 | 12832451 | |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 5.71e-06 | 13 | 96 | 3 | 21670291 | |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 22162753 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 2702644 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 8380065 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 1279194 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 25724769 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 5.71e-06 | 13 | 96 | 3 | 22092845 | |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 11801635 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 5.71e-06 | 13 | 96 | 3 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 5.71e-06 | 13 | 96 | 3 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 5.71e-06 | 13 | 96 | 3 | 23800882 | |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 19285068 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 21760897 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 5.71e-06 | 13 | 96 | 3 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 5.71e-06 | 13 | 96 | 3 | 39168268 | |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 8402684 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 16619040 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 5.71e-06 | 13 | 96 | 3 | 8209741 | |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 5.71e-06 | 13 | 96 | 3 | 21949477 | |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 26219866 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 2133556 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 32521208 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 19406938 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 5.71e-06 | 13 | 96 | 3 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 5.71e-06 | 13 | 96 | 3 | 19358828 | |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 16680193 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 5.71e-06 | 13 | 96 | 3 | 34058224 | |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 10964771 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 32169849 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 5.71e-06 | 13 | 96 | 3 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 5.71e-06 | 13 | 96 | 3 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 5.71e-06 | 13 | 96 | 3 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 5.71e-06 | 13 | 96 | 3 | 23935487 | |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 15331748 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 5.71e-06 | 13 | 96 | 3 | 22406619 | |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 5.71e-06 | 13 | 96 | 3 | 25972571 | |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 19008452 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 5.71e-06 | 13 | 96 | 3 | 15220458 | |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 18843289 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 15207636 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 21081647 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 11133662 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 11483763 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 2164599 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 29396368 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 18003729 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 5.71e-06 | 13 | 96 | 3 | 33352461 | |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 38381498 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 20739537 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 5.71e-06 | 13 | 96 | 3 | 27695943 | |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 20404914 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 5.71e-06 | 13 | 96 | 3 | 32027621 | |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 5.71e-06 | 13 | 96 | 3 | 27777319 | |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 18848945 | ||
| Pubmed | 7.26e-06 | 14 | 96 | 3 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 7.26e-06 | 14 | 96 | 3 | 34666041 | |
| Pubmed | 7.26e-06 | 14 | 96 | 3 | 34619794 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 7.26e-06 | 14 | 96 | 3 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 7.26e-06 | 14 | 96 | 3 | 32209360 | |
| Pubmed | 7.26e-06 | 14 | 96 | 3 | 11994468 | ||
| Pubmed | 7.26e-06 | 14 | 96 | 3 | 11850617 | ||
| Pubmed | 7.26e-06 | 14 | 96 | 3 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 7.26e-06 | 14 | 96 | 3 | 26196244 | |
| Pubmed | 7.26e-06 | 14 | 96 | 3 | 8896983 | ||
| Pubmed | 7.26e-06 | 14 | 96 | 3 | 22962327 | ||
| Pubmed | 7.26e-06 | 14 | 96 | 3 | 17623671 | ||
| Pubmed | 7.26e-06 | 14 | 96 | 3 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 7.26e-06 | 14 | 96 | 3 | 18794798 | |
| Pubmed | 7.26e-06 | 14 | 96 | 3 | 23469261 | ||
| Pubmed | 7.26e-06 | 14 | 96 | 3 | 18454175 | ||
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 7.06e-08 | 11 | 71 | 4 | 1315 | |
| GeneFamily | Fibronectin type III domain containing | 4.15e-04 | 160 | 71 | 5 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.27e-04 | 161 | 71 | 5 | 593 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 5.38e-04 | 9 | 71 | 2 | 1203 | |
| GeneFamily | Immunoglobulin like domain containing | 9.69e-04 | 193 | 71 | 5 | 594 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.18e-03 | 53 | 71 | 3 | 532 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 4.48e-03 | 394 | 71 | 6 | 471 | |
| Coexpression | GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_UP | 6.69e-07 | 135 | 96 | 7 | M2916 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-07 | 184 | 96 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-07 | 184 | 96 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-07 | 184 | 96 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal-Intermediate|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 4.76e-06 | 200 | 96 | 6 | 401d50fa394fa863fa7836344110ae5c7af3250a | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.30e-05 | 157 | 96 | 5 | 8c42af7aa1f1b6f4fe2f8d00a8b4a800f121e804 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.30e-05 | 157 | 96 | 5 | ee1be3c756b72fceac6b4ccb416dd4bd031a2193 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.30e-05 | 157 | 96 | 5 | 008f938a338f43c3251dcac574f1b4f689926c71 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 2.44e-05 | 159 | 96 | 5 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Chat_(Habenular_cholinergic_cells)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.00e-05 | 82 | 96 | 4 | 51dd9ab3ddb26d3d3395d0c1a156a12a86caf89b | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.41e-05 | 180 | 96 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 184 | 96 | 5 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.03e-05 | 185 | 96 | 5 | 0094f9baddb20214d2a2c166f1637d1a9cf1169a | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.34e-05 | 95 | 96 | 4 | 3699ea16660a22ea79fecfea56ece2dfb0f13467 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.34e-05 | 95 | 96 | 4 | cbfe615d880913bafaf5e7e8d24c3ec14a9351ce | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.34e-05 | 95 | 96 | 4 | 27ac23b87747434a3084cc087e7b884e68f0eab9 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 5.43e-05 | 188 | 96 | 5 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.43e-05 | 188 | 96 | 5 | 91fa9cc29cbc88d3c29590ecee5c8ce858ac0aa7 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.56e-05 | 189 | 96 | 5 | 6f4f2911fcbf3b43718b6183dbd9c970d4c19607 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 5.56e-05 | 189 | 96 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.99e-05 | 192 | 96 | 5 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 194 | 96 | 5 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.30e-05 | 194 | 96 | 5 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Healthy-B_intermediate|Healthy / disease group, cell group and cell class | 6.30e-05 | 194 | 96 | 5 | aabee48bf689367edae2079b4b90d253715f1097 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 194 | 96 | 5 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | Healthy-B_intermediate|World / disease group, cell group and cell class | 6.45e-05 | 195 | 96 | 5 | 9de79e0bdd9063ae65e5edb89cc3fe6f9a8173bc | |
| ToppCell | Goblet_cell|World / shred on cell type and cluster | 6.77e-05 | 197 | 96 | 5 | d82d3204f24c95771c1496c28e3fbc6e2442199b | |
| ToppCell | C_04|World / shred on cell type and cluster | 6.77e-05 | 197 | 96 | 5 | 885604356e19a850b0e601c3167ad26b8180bcec | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 6.77e-05 | 197 | 96 | 5 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.93e-05 | 198 | 96 | 5 | 55e583321f60c95898d93cd0d2615c6692db52ec | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.93e-05 | 198 | 96 | 5 | df546a9afc0e15398f33c1b511c7281771f9aea0 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.93e-05 | 198 | 96 | 5 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.10e-05 | 199 | 96 | 5 | e19b296d583f8bad3b66ee998a8153634d6fe09e | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.10e-05 | 199 | 96 | 5 | 801887db51ac5dc5b068808ff75e3a46643398e9 | |
| Drug | AC1L1IPV | 8.68e-07 | 43 | 93 | 5 | CID000004683 | |
| Disease | cD177 antigen measurement | 2.02e-05 | 18 | 88 | 3 | EFO_0021866 | |
| Disease | D dimer measurement | 9.82e-05 | 30 | 88 | 3 | EFO_0004507 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 1.31e-04 | 6 | 88 | 2 | C1854678 | |
| Disease | hydrocephalus (is_implicated_in) | 1.31e-04 | 6 | 88 | 2 | DOID:10908 (is_implicated_in) | |
| Disease | asparaginase-induced acute pancreatitis | 3.12e-04 | 9 | 88 | 2 | EFO_1001507 | |
| Disease | cognitive disorder (is_implicated_in) | 3.12e-04 | 9 | 88 | 2 | DOID:1561 (is_implicated_in) | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 3.90e-04 | 10 | 88 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 3.90e-04 | 10 | 88 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | smoking status measurement, forced expiratory volume | 4.75e-04 | 11 | 88 | 2 | EFO_0004314, EFO_0006527 | |
| Disease | visual perception measurement | 5.55e-04 | 223 | 88 | 5 | EFO_0009700 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 5.69e-04 | 12 | 88 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) measurement | 5.69e-04 | 12 | 88 | 2 | EFO_0800453 | |
| Disease | level of Phosphatidylcholine (16:1_18:1) in blood serum | 6.71e-04 | 13 | 88 | 2 | OBA_2045082 | |
| Disease | focal segmental glomerulosclerosis | 1.03e-03 | 16 | 88 | 2 | EFO_0004236 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 1.03e-03 | 16 | 88 | 2 | C1839071 | |
| Disease | vision disorder | 1.03e-03 | 16 | 88 | 2 | MONDO_0021084 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 1.03e-03 | 16 | 88 | 2 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 1.03e-03 | 16 | 88 | 2 | 415000 | |
| Disease | level of Phosphatidylcholine (18:0_20:3) in blood serum | 1.03e-03 | 16 | 88 | 2 | OBA_2045093 | |
| Disease | level of Phosphatidylcholine (14:0_18:2) in blood serum | 1.16e-03 | 17 | 88 | 2 | OBA_2045063 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 1.45e-03 | 19 | 88 | 2 | OBA_2045199 | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 1.78e-03 | 21 | 88 | 2 | OBA_2045083 | |
| Disease | Cleft Palate | 1.85e-03 | 81 | 88 | 3 | C0008925 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WKRITKLDIYEGYGQ | 356 | Q6P461 | |
| QYYNETLGKTLWRGK | 366 | Q14264 | |
| NTQYLVRWKGYDKQD | 21 | Q9Y6F8 | |
| NTQYLVRWKGYDKQD | 21 | Q9Y6F7 | |
| LKSKFWVNEQRYGGI | 1546 | P78363 | |
| VKYGKWRGQYDVAIK | 416 | Q06187 | |
| DYYKKTSNGRLPVKW | 641 | P22455 | |
| LILGITAWGYKNYRE | 751 | Q9P0K1 | |
| KLKSYLQQHGYGSWI | 551 | Q96M93 | |
| GLSWKSQNGRLYSIK | 431 | Q9Y5C1 | |
| VTYKNLKFQVWDLGG | 56 | P40616 | |
| QRVGNKEAYKWYELG | 536 | Q12797 | |
| YKWYLKELQDGIGQR | 2141 | P11532 | |
| LTIYNAYLGWKKARQ | 1136 | Q7Z478 | |
| YKWILTRNYKALSKG | 726 | O14646 | |
| VRSLSQKYYLTGGWS | 791 | Q8TE60 | |
| TQISGYKLYWREVGA | 656 | Q8TDY8 | |
| NKLAIFGIGYNTRWK | 311 | Q6P1R3 | |
| WVNGIRIAKYGKQLY | 496 | Q70E73 | |
| ELVNNYGKGWSLKYR | 191 | Q13702 | |
| GIRKWYYNAAGFNKL | 16 | P14927 | |
| TGFQRKLIYQTLSWK | 206 | O95453 | |
| TKYYSEWKGGRKNTN | 36 | Q969Q6 | |
| GLQYVDSKGYSTWLK | 46 | P35241 | |
| AQYDGAYKVSRGLWK | 61 | P11177 | |
| ISSYLNWYRQKPGKV | 51 | P0DSN7 | |
| YGWTAPRQYKNQKES | 321 | Q9BRR8 | |
| GKTYISKKLTRYLNW | 51 | Q16877 | |
| QRKCYYFGKGTKQWV | 171 | P06734 | |
| RYLVADKYWKKNGGS | 71 | P42785 | |
| YKIYDLQLWNGLLQK | 1971 | P50748 | |
| GLQYQDTKGFSTWLK | 46 | P26038 | |
| PYYKNAGIGWKNSIR | 101 | Q9P0K8 | |
| TINYLLGKFSQKTRW | 181 | P49961 | |
| WDLNRLLYKAQGVYS | 226 | O95672 | |
| YEYLLKQWIQGGKQE | 466 | Q9UKM7 | |
| WYKDGALLTTGNKFQ | 6141 | Q5VST9 | |
| VWNIIGKAYSTDYKL | 141 | O43283 | |
| GQYRTVLYDSWVKQL | 3166 | Q9P2D7 | |
| GGLKAAYNAYKAWLR | 786 | P0DPD8 | |
| EKLWYYSQLQGLSKR | 151 | O95996 | |
| AGYWKKEYITKQIAS | 151 | Q8NCQ5 | |
| LWYKGAVGLNLQSKT | 146 | Q96LA6 | |
| KGSLSYLNVTRKAYW | 256 | P07339 | |
| TIRWLKNGYAYHKGE | 361 | Q12860 | |
| WNAGKLTYIDTKYVV | 146 | Q5VWK5 | |
| YLKLEKGNLVGGWQY | 176 | Q9NTU7 | |
| GKSNAWLRQKNAGIY | 556 | Q9P203 | |
| WYVALKRTGQYKLGS | 256 | P09038 | |
| ISSYLNWYRQKPGKV | 51 | A0A075B6S9 | |
| WYYLFTQGKKGRLTS | 51 | Q17R55 | |
| NLTGYIWYKGQIRDL | 61 | Q9UQ72 | |
| KNGILTGYRISWEEY | 921 | Q58EX2 | |
| SYAWYRGSKLIQTAG | 166 | Q9BZW8 | |
| NYAIKGNWIGESPYK | 206 | Q9H3Y0 | |
| GGKVLYKVRWKGYTS | 71 | Q99549 | |
| NETWKGVFIYQGKLL | 96 | Q5VZ72 | |
| LGTLWLGYTLYQFKK | 566 | Q8NBS3 | |
| LAKYTDGNWYRGIVI | 1041 | O60522 | |
| QTWSKRLYGVYDNEK | 281 | Q8N7P1 | |
| GSQGYKYNWKLDEAR | 306 | Q9Y285 | |
| KQGNLYEFLKLTGWR | 366 | Q86UY8 | |
| NLTGYIWYKGQIRDL | 61 | Q9UQ74 | |
| TTKYYRLLSKRGGWV | 291 | Q14190 | |
| NLTGYIWYKGQIRDL | 61 | Q13046 | |
| YNGWVLYVNGREKIT | 1486 | Q4LDE5 | |
| ILGAAYKYKNEQGWR | 121 | Q92922 | |
| YLGETIAQWRKAGYQ | 661 | Q15437 | |
| IDKYNYTLWKGQLLN | 351 | Q9UK61 | |
| SYFQTKWENYLKLRG | 221 | P54922 | |
| TGSLRKIKGSYDYWV | 161 | Q6UXN8 | |
| KGLGNISAKYRWFAV | 516 | O95436 | |
| GDYLWRKYNGAIQVV | 231 | P09544 | |
| GYSWKNIRERYGTLT | 1331 | O75970 | |
| YNWSFKYTGNIIKGV | 156 | O15270 | |
| KDVLKGQNWLIYTYG | 146 | O95235 | |
| YKGKWLYEVLISSQG | 131 | Q5XPI4 | |
| REGWLYYKQILTKKG | 691 | Q9P227 | |
| VWYTDLNQQKKIYTG | 611 | Q8TF20 | |
| WQIGEIASKIGQLYY | 121 | Q8N9R8 | |
| YWENLYQLTLRAAGK | 371 | Q9UQD0 | |
| GVKYIIQWKYAQLLG | 126 | P08922 | |
| RKYGEGNWSKILLHY | 396 | P54274 | |
| WGVLKSRGLLYKGVY | 151 | Q96GW9 | |
| GNIKRYGWKKQYVVV | 1131 | Q13464 | |
| NGFWVVQLSKGTKYL | 386 | Q9Y577 | |
| GESVIQVSGKYKWYL | 91 | O60844 | |
| WTYKKLEIGFNGNRI | 156 | Q9HD45 | |
| KYTYWGQKEGDLRSV | 256 | Q9BXU3 | |
| WEKLYQQTLRTTGLY | 361 | Q9UI33 | |
| NLTGYIWYKGQIRDL | 61 | P11465 | |
| WFGDSRYALKNGQLK | 811 | Q9H4I2 | |
| TKYDLNWLVKNSYEG | 126 | Q9NVH6 | |
| YWKSGKVGKLVNQSY | 66 | A8MT70 | |
| AKSVEQYYGWNIGKR | 1176 | Q9ULM3 | |
| QYLYKEGWERQKATG | 4211 | P20929 |